Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18510179 | 1.00 | PARL (0.35) | PARLALOX12 | |
| Formaldehyde SCHEMBL15307446 | 0.95 | PARL (0.33) | PARL | |
| SCHEMBL21427229 | 0.89 | BRD4 (0.33) | — | |
| SCHEMBL18875534 | 0.83 | PARL (0.31) | PARL | |
| SCHEMBL12832045 | 0.83 | PARL (0.31) | PARL | |
| SCHEMBL12019203 | 0.78 | PARL (0.33) | PARL | |
| SCHEMBL14571852 | 0.78 | PARL (0.33) | PARL | |
| SCHEMBL9123590 | 0.74 | PARL (0.34) | PARLALOX12 | |
| SCHEMBL182701 | 0.71 | PARL (0.39) | PARLALOX12 | |
| SCHEMBL8348981 | 0.71 | PARL (0.39) | PARLALOX12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1732 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4720075-A1 | TOPOISOMERASE INHIBITORS, METHODS OF MAKING, AND METHODS OF USE THEREOF | NJ Bio, Inc. (US) | 2026-04-08 | — | — | EP | claimed |
| US-20260022127-A1 | HEXACYCLIC TOPOISOMERASE INHIBITORS HAVING CYTOTOXIC ACTIVITY ON CANCER CELLS | NJ BIO INC (US) | 2026-01-22 | — | — | US | claimed |
| EP-4558506-A1 | HEXACYCLIC TOPOISOMERASE INHIBITORS HAVING CYTOTOXIC ACTIVITY ON CANCER CELLS | NJ Bio, Inc. (US) | 2025-05-28 | — | — | EP | claimed |
| CN-119587474-A | Liver-targeted chemotherapeutic drug nano micelle preparation method, chemotherapeutic drug and application | 中国人民解放军新疆军区总医院 | 2025-03-11 | — | — | CN | claimed |
| WO-2024248944-A1 | TOPOISOMERASE INHIBITORS, METHODS OF MAKING, AND METHODS OF USE THEREOF | NJ BIO, INC. (US) | 2024-12-05 | — | — | WO | claimed |
| US-12076416-B2 | Gene editing nanocapsule and preparation method and use thereof | HENAN UNIVERSITY (CN) | 2024-09-03 | — | — | US | claimed |
| EP-4371662-A1 | METHOD FOR ANALYZING REACTIVE LOW-MOLECULAR-WEIGHT COMPOUND CONTAINED IN POLYOXYETHYLENE DERIVATIVE | NOF Corporation (JP) | 2024-05-22 | — | — | EP | claimed |
| US-11945882-B2 | Method for producing antibody-drug conjugate | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2024-04-02 | — | — | US | claimed |
| CN-116790136-B | Carboxylic acid succinimide ester dye and reactive dyeing method thereof | 现代纺织技术创新中心(鉴湖实验室) | 2024-04-02 | — | — | CN | claimed |
| WO-2024020536-A1 | HEXACYCLIC TOPOISOMERASE INHIBITORS HAVING CYTOTOXIC ACTIVITY ON CANCER CELLS | NJ BIO, INC. (US) | 2024-01-25 | — | — | WO | claimed |
| EP-0263657-B1 | POLYSUBSTITUTED ARYL ACRIDINIUM ESTERS | Ciba Corning Diagnostics Corp. (US) | 1992-05-13 | — | — | EP | claimed |
| EP-0460026-A1 | HIGH PERFORMANCE AFFINITY CHROMATOGRAPHY COLUMN COMPRISING NON-POROUS, MONODISPERSE POLYMERIC PACKING MATERIAL | EASTMAN KODAK COMPANY (US) | 1991-12-11 | — | — | EP | claimed |
| WO-1990009832-A1 | HIGH PERFORMANCE AFFINITY CHROMATOGRAPHY COLUMN COMPRISING NON-POROUS, MONODISPERSE POLYMERIC PACKING MATERIAL | EASTMAN KODAK COMPANY (US) | 1990-09-07 | — | — | WO | claimed |
| US-4927769-A | OXIDIZING AN ACRIDINIUM ESTER IN THE PRESENCE OF A CATIONIC SURFACTANT, NONIONIC SURFACTANT OR SULFATED PRIMARY ALCOHOL | CIBA CORNING DIAGNOSTICS CORP. (US) | 1990-05-22 | — | — | US | claimed |
| US-4774339-A | TRACERS; IMMUNOASSAY; FLUORESCENT DYES | MOLECULAR PROBES, INC. (US) | 1988-09-27 | — | — | US | claimed |
| EP-0134225-B1 | NEW ALKYL DIAMINE DERIVATIVES | ALKALOIDA VEGYéSZETI GYáR (HU) | 1988-08-17 | — | — | EP | claimed |
| EP-0071926-B1 | NEW RIBOFURANURONIC ACID DERIVATIVES, PROCESSES FOR PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS THEREOF | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1986-10-08 | — | — | EP | claimed |
| EP-0134225-A1 | NEW ALKYL DIAMINE DERIVATIVES. | ALKALOIDA VEGYESZETI GYAR (HU) | 1985-03-20 | — | — | EP | claimed |
| WO-1984002907-A1 | NEW ALKYL DIAMINE DERIVATIVES | ALKALOIDA VEGYESZETI GYAR (HU) | 1984-08-02 | — | — | WO | claimed |
| EP-0071926-A1 | New ribofuranuronic acid derivatives, processes for preparation thereof and pharmaceutical compositions thereof | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1983-02-16 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260022127-A1 | HEXACYCLIC TOPOISOMERASE INHIBITORS HAVING CYTOTOXIC ACTIVITY ON CANCER CELLS | TOP1, TOP2A, TOP2B | PARL 4754/4885ALOX12 3191/4885 |
| US-12076416-B2 | Gene editing nanocapsule and preparation method and use thereof | RNASE1, LDLR, CASK | PARL 1291/4885ALOX12 1107/4885 |
| US-11945882-B2 | Method for producing antibody-drug conjugate | UGT1A9, ALB, MRPL21 | PARL 4624/4885ALOX12 3931/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.